Elliott F Winton MD

Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 11-18 of 18

  1. 1
  2. 2

Article

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naive Patients With Myelofibrosis

by Ruben A. Mesa; Jean-Jacques Kiladjian; John V. Catalano; Timothy Devos; Miklos Egyed; Andrzei Hellmann; Donal McLornan; Kazuya Shimoda; Elliott Winton; Wei Deng; Ronald L. Dubowy; Julia D. Maltzman; Francisco Cervantes; Jason Gotlib

2017

Article

Ruxolitinib for the treatment of patients with polycythemia vera

by Jean-Jacques Kiladjian; Elliott Winton; Moshe Talpaz; Srdan Verstovsek

2015

Article

Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts

by Moshe Talpaz; Ronald Paquette; Lawrence Afrin; Solomon I Hamburg; Josef T Prchal; Katarzyna Jamieson; Howard R Terebelo; Gregory L Ortega; Roger M Lyons; Ramon V Tiu; Elliott Winton; Kavita Natrajan; Olatoyosi Odenike; David Claxton; Wei Peng; Peter O’Neill; Susan Erickson-Viitanen; Lance Leopold; Victor Sandor; Richard S Levy; Hagop M Kantarjian; Srdan Verstovsek

2013

Article

Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I

by Srdan Verstovsek; Ruben A. Mesa; Jason Gotlib; Richard S. Levy; Vikas Gupta; John F. DiPersio; John V. Catalano; Michael W. N. Deininger; Carole B. Miller; Richard T. Silver; Moshe Talpaz; Elliott Winton; Jimmie H. Harvey; Murat O. Arcasoy; Elizabeth O. Hexner; Roger M. Lyons; Ronald Paquette; Azra Raza; Kris Vaddi; Susan Erickson-Viitanen; William Sun; Victor Sandor; Hagop M. Kantarjian

2013

Article

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

by Ruben A. Mesa; Jean-Jacques Kiladjian; Srdan Verstovsek; Haifa Kathrin Al-Ali; Jason Gotlib; Heinz Gisslinger; Richard Levy; Andres Siulnik; Vikas Gupta; Mahmudul Khan; John F. DiPersio; Mari McQuitty; John V. Catalano; Deborah S. Hunter; Laurent Knoops; Michael Deininger; Francisco Cervantes; Carole Miller; Alessandro M. Vannucchi; Richard T. Silver; Tiziano Barbui; Moshe Talpaz; Giovanni Barosi; Elliot F. Mendeson; Elliott Winton; Jimmie H. Harvey; Murat O. Arcasoy; Elizabeth Hexner; Roger M. Lyons; ROnald Paquette; Azra Raza; William Sun; Victor Sandor; Hagop M. Kantarjian; Claire Harrison

2014

Article

Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia

by Kim-Hien T. Dao; Magdolna B. Solti; Julia E. Maxson; Elliott Winton; Richard D. Press; Brian J. Druker; Jeffrey W. Tyner

2014

Article

Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors

by Jee Kong; Elliott Winton; Leonard T. Heffner; Manila Gaddh; Brittany Hill; Jessica Neely; Angela Hatcher; Meena Joseph; Martha Arellano; Fuad El-Rassi; Audrey Kim; H Jean Khoury; Vamsi Kota

2020